Article
Nerve growth factor mediates peripheral mechanical hypersensitivity that accompanies experimental cystitis in mice.
Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin, 2015 Linden Dr., Madison, 53706, USA.
Neuroscience Letters (impact factor:
2.11).
02/2006;
392(3):193-7.
DOI:10.1016/j.neulet.2005.09.026
pp.193-7
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Mast cell-derived histamine mediates cystitis pain.
[show abstract] [hide abstract]
ABSTRACT: Mast cells trigger inflammation that is associated with local pain, but the mechanisms mediating pain are unclear. Interstitial cystitis (IC) is a bladder disease that causes debilitating pelvic pain of unknown origin and without consistent inflammation, but IC symptoms correlate with elevated bladder lamina propria mast cell counts. We hypothesized that mast cells mediate pelvic pain directly and examined pain behavior using a murine model that recapitulates key aspects of IC. Infection of mice with pseudorabies virus (PRV) induces a neurogenic cystitis associated with lamina propria mast cell accumulation dependent upon tumor necrosis factor alpha (TNF), TNF-mediated bladder barrier dysfunction, and pelvic pain behavior, but the molecular basis for pelvic pain is unknown. In this study, both PRV-induced pelvic pain and bladder pathophysiology were abrogated in mast cell-deficient mice but were restored by reconstitution with wild type bone marrow. Pelvic pain developed normally in TNF- and TNF receptor-deficient mice, while bladder pathophysiology was abrogated. Conversely, genetic or pharmacologic disruption of histamine receptor H1R or H2R attenuated pelvic pain without altering pathophysiology. These data demonstrate that mast cells promote cystitis pain and bladder pathophysiology through the separable actions of histamine and TNF, respectively. Therefore, pain is independent of pathology and inflammation, and histamine receptors represent direct therapeutic targets for pain in IC and other chronic pain conditions.PLoS ONE 02/2008; 3(5):e2096. · 4.09 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
CYP administration
CYP induced bladder inflammation
CYP treatment
female mice
hind paws
Increased sensitivity
intraperitoneal injection
intravenous NGF antiserum
K252a intravenously 30 min
mechanical stimulation
mechanical stimuli
nerve growth factor
NGF antiserum
normal serum
prior treatment
somatic stimuli
thermal stimuli
visceral inflammation
visceral pain causes
withdrawal threshold